Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate
- 8 May 2014
- journal article
- Published by Springer Nature in World Journal of Urology
- Vol. 33 (3) , 329-333
Abstract
Recently, more vaporization techniques are available for the treatment of benign prostate hyperplasia (BPH). However, the detection of incidental prostate cancer (Pca) is impossible in vaporization techniques because of unavailability prostate tissue for histopathological analysis. To evaluate the clinical backgrounds and the usefulness of prostate-specific antigen (PSA)-related factors in incidental Pca, we employed our BPH patients cohort treated by holmium laser enucleation of the prostate (HoLEP). A total of 365 HoLEPs were performed by a single surgeon. The pathological results and pre- and post-HoLEP PSA, PSA density and PSA velocity were analyzed retrospectively. Incidental Pca was identified in 25 (6.8 %) of the 365 patients treated with HoLEP. There were significant differences between BPH and Pca in terms of prostate volume (55.5 vs. 47 ml, p = 0.0365), preoperative PSA (4.50 vs. 7.14 ng/ml, p = 0.0107), PSA density (0.079 vs. 0.155 ng/ml/cm3, p = 0.0005), and postoperative PSA velocity (0.04 vs. 0.22 ng/ml/year, p = 0.0033), respectively. Comparisons of Gleason score subgroups in the 25 patients with incidental Pca identified significant differences in preoperative PSA (6.06 vs. 21.6 ng/ml, p = 0.0191) and postoperative PSA velocity (0.185 vs. 1.32 ng/ml/year, p = 0.0382) between the Gleason score 3 + 3 and Gleason score >3 + 3 groups, respectively. Risk factors associated with incidental Pca were smaller prostate volume, higher preoperative PSA, and higher PSA density. Postoperative PSA velocity was also significantly increased in patients with incidental Pca, especially those with higher Gleason score. These finding may be useful in incident Pca patients treated by the vaporization technique.Keywords
This publication has 14 references indexed in Scilit:
- Comparison of transurethral enucleation with bipolar and transurethral resection in saline for managing benign prostatic hyperplasiaBJU International, 2012
- Incidental prostate cancer revisited: Early outcomes after holmium laser enucleation of the prostateInternational Journal of Urology, 2011
- Predicting 15-Year Prostate Cancer Specific Mortality After Radical ProstatectomyJournal of Urology, 2011
- Prostatic-specific Antigen Velocity After Holmium Laser Enucleation of the Prostate: Possible Predictor for the Assessment of Treatment Effect Durability for Benign Prostatic Hyperplasia and Detection of MalignancyUrology, 2009
- Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasiaInternational Journal of Urology, 2009
- Outcome of radical prostatectomy for incidental carcinoma of the prostateBJU International, 2009
- Radical Prostatectomy for Incidental (Stage T1a–T1b) Prostate Cancer: Analysis of Predictors for Residual Disease and Biochemical RecurrenceEuropean Urology, 2008
- Prostate Specific Antigen Working Group Guidelines on Prostate Specific Antigen Doubling TimeJournal of Urology, 2008
- Change in Serum Prostate Specific Antigen Concentration after Holmium Laser Enucleation of the Prostate: A Marker for Completeness of Adenoma Resection?Journal of Endourology, 2005
- Holmium Laser Enucleation Versus Transurethral Resection of the Prostate. Are Histological Findings Comparable?Journal of Urology, 2004